These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 23343162)
1. Nanomedicine in chemoradiation. Miller SM; Wang AZ Ther Deliv; 2013 Feb; 4(2):239-50. PubMed ID: 23343162 [TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy of human tumors: novel approaches from nanomedicine. Werner ME; Foote MB; Wang AZ Curr Pharm Des; 2012; 18(19):2830-7. PubMed ID: 22390766 [TBL] [Abstract][Full Text] [Related]
3. Improving chemoradiotherapy with nanoparticle therapeutics. Eblan MJ; Wang AZ Transl Cancer Res; 2013 Aug; 2(4):320-329. PubMed ID: 25429359 [TBL] [Abstract][Full Text] [Related]
4. Polysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapy. Rocca JD; Werner ME; Kramer SA; Huxford-Phillips RC; Sukumar R; Cummings ND; Vivero-Escoto JL; Wang AZ; Lin W Nanomedicine; 2015 Jan; 11(1):31-8. PubMed ID: 25038495 [TBL] [Abstract][Full Text] [Related]
5. Nanomedicine in veterinary oncology. Lin TY; Rodriguez CO; Li Y Vet J; 2015 Aug; 205(2):189-97. PubMed ID: 25862394 [TBL] [Abstract][Full Text] [Related]
6. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Hatami E; Jaggi M; Chauhan SC; Yallapu MM Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188381. PubMed ID: 32492470 [TBL] [Abstract][Full Text] [Related]
7. Role of concomitant chemoradiation in locally advanced head and neck cancers. Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361 [TBL] [Abstract][Full Text] [Related]
8. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches. Jäger E; Giacomelli FC Curr Top Med Chem; 2015; 15(4):328-44. PubMed ID: 25633209 [TBL] [Abstract][Full Text] [Related]
9. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Ganipineni LP; Danhier F; Préat V J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958 [TBL] [Abstract][Full Text] [Related]
10. Cancer nanomedicine: from targeted delivery to combination therapy. Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384 [TBL] [Abstract][Full Text] [Related]
11. Treatment of locally advanced pancreatic cancer: the role of radiation therapy. Johung K; Saif MW; Chang BW Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):508-18. PubMed ID: 22075449 [TBL] [Abstract][Full Text] [Related]
12. New Strategies in Cancer Nanomedicine. Tong R; Kohane DS Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197 [TBL] [Abstract][Full Text] [Related]
13. Combination Approach: the Future of the War Against Cancer. Chen L; Malhotra A Cell Biochem Biophys; 2015 Jul; 72(3):637-41. PubMed ID: 25638344 [TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems. Molinaro M; Skrodzki D; Pan D Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1984. PubMed ID: 39109509 [TBL] [Abstract][Full Text] [Related]
15. Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer. Caster JM; Wang AZ Ther Deliv; 2017 Aug; 8(9):791-803. PubMed ID: 28825397 [TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape? Lee M; Gibbs P; Wong R Clin Colorectal Cancer; 2015 Dec; 14(4):251-61. PubMed ID: 26210575 [TBL] [Abstract][Full Text] [Related]
17. Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming. Wang J; Lu Z; Gao Y; Wientjes MG; Au JL Nanomedicine (Lond); 2011 Nov; 6(9):1605-20. PubMed ID: 22077464 [TBL] [Abstract][Full Text] [Related]
18. Nanomedicine: the promise and challenges in cancer chemotherapy. Naguib YW; Cui Z Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034 [No Abstract] [Full Text] [Related]
19. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
20. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. Bar-Zeev M; Livney YD; Assaraf YG Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]